Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV)
- 26 December 2007
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 77 (3) , 225-231
- https://doi.org/10.1016/j.antiviral.2007.11.009
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: